Evaluation of brainstem involvement in multiple sclerosis

ISSN： 1473-7175

Source： Expert Review of Neurotherapeutics, Vol.13, Iss.3, 2013-03, pp. : 299-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of mitoxantrone for the treatment of multiple sclerosis

By Jain K.K.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 5, 2000-05 ,pp. : 1139-1149

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1219-1228

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

By Wiese Michael D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1025-1035

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Multiple Sclerosis in the UK, Germany and France

By Murphy N.

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 607-622

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis

By Tanasescu Radu Constantinescu Cris S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 621-630

Informa Healthcare

Access to resources Recommend Favorite